19671811000001109: Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Topotecan\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Topotecan\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing topoisomerase inhibitor\Product containing topotecan\Topotecan\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing topoisomerase inhibitor\Product containing topotecan\Topotecan\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing topoisomerase inhibitor\Product containing topotecan\Product containing topotecan in parenteral dose form (medicinal product form)\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing topotecan\Topotecan\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing topotecan\Topotecan\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing topotecan\Product containing topotecan in parenteral dose form (medicinal product form)\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing topotecan\Topotecan\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing topotecan\Topotecan\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing topotecan\Product containing topotecan in parenteral dose form (medicinal product form)\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing topotecan in parenteral dose form (medicinal product form)\Product containing only topotecan in parenteral dose form (medicinal product form)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection\Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Dec 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

66538501000001114 Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

66538601000001113 Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Is a	Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has active ingredient	Topotecan	false	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has manufactured dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has specific active ingredient	Topotecan hydrochloride	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has dispensed dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Topotecan	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has basis of strength substance	Topotecan	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Has manufactured dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial	Has AMP	True	Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
66538501000001114	Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
66538601000001113	Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module